Carl R. Iberger
2018
In 2018, Carl R. Iberger earned a total compensation of $403.2K as Chief Financial Officer at Transgenomic.
Compensation breakdown
| Option Awards | $195,000 |
|---|---|
| Salary | $200,000 |
| Other | $8,160 |
| Total | $403,160 |
Iberger received $200K in salary, accounting for 50% of the total pay in 2018.
Iberger also received $195K in option awards and $8.2K in other compensation.
Rankings
In 2018, Carl R. Iberger's compensation ranked 12,511th out of 14,244 executives tracked by ExecPay. In other words, Iberger earned more than 12.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,511 out of 14,244 | 12th |
Division Manufacturing | 5,063 out of 5,762 | 12th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 705 out of 849 | 17th |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 189 out of 227 | 17th |
Industry Laboratory Analytical Instruments | 60 out of 67 | 10th |
Source: SEC filing on April 29, 2020.
Iberger's colleagues
We found three more compensation records of executives who worked with Carl R. Iberger at Transgenomic in 2018.